Bingjun Guo1, Xin Jiang2, Xiaoqiao Hu2, Fan Li3, Xiaopin Chen2. 1. Department of Ultrasound, The First Affiliated Hospital of Chongqing Medical University Chongqing 400016, P. R. China. 2. Department of Oncology, The First Affiliated Hospital of Chongqing Medical University Chongqing 400016, P. R. China. 3. Department of Endocrine and Breast Surgery, The First Affiliated Hospital of Chongqing Medical University Chongqing 400016, P. R. China.
Abstract
OBJECTIVE: The present study aimed to explore the association between vitamin D receptor (VDR) genetic polymorphisms and breast cancer risk. METHODS: A total of 219 patients with breast cancer and 321 cases of females without breast cancer were enrolled for the present study. PCR-RFLP method was used to genotype 3 SNPs of the VDR gene (rs1544410, rs7975232 and rs731236). ELISA method was used to detect the amount of 1,25(OH)2D3 in the plasma. The results were analyzed using SPSS 17.0 software. RESULTS: We found rs7975232 was associated with breast cancer risk. Compared with GG genotype carriers, TT subjects had a lower risk of breast cancer (P = 0. 004, OR = 0.774, 95% CI: 0.212~0.955). However, there was no difference in 1,25(OH)2D3 levels among the different genotypes. In addition, the distribution frequency of the haplotype A-G-T in the patients group was 4.4%, significantly higher than the control group (0.7%, P = 0.003; OR=2.643, 95% CI: 1.631~7.012), while the distribution of haplotype G-T-T in the patient group was significantly lower than in the control group (17.3% vs. 28.4%, P = 0.011, OR = 0.543, 95% CI: 0.325~0.854). CONCLUSIONS: The VDR gene was associated with breast cancer pathogenesis; females carrying the haplotype G-T-T had a lower breast cancer risk, while the haplotype A-G-T conferred a higher risk.
OBJECTIVE: The present study aimed to explore the association between vitamin D receptor (VDR) genetic polymorphisms and breast cancer risk. METHODS: A total of 219 patients with breast cancer and 321 cases of females without breast cancer were enrolled for the present study. PCR-RFLP method was used to genotype 3 SNPs of the VDR gene (rs1544410, rs7975232 and rs731236). ELISA method was used to detect the amount of 1,25(OH)2D3 in the plasma. The results were analyzed using SPSS 17.0 software. RESULTS: We found rs7975232 was associated with breast cancer risk. Compared with GG genotype carriers, TT subjects had a lower risk of breast cancer (P = 0. 004, OR = 0.774, 95% CI: 0.212~0.955). However, there was no difference in 1,25(OH)2D3 levels among the different genotypes. In addition, the distribution frequency of the haplotype A-G-T in the patients group was 4.4%, significantly higher than the control group (0.7%, P = 0.003; OR=2.643, 95% CI: 1.631~7.012), while the distribution of haplotype G-T-T in the patient group was significantly lower than in the control group (17.3% vs. 28.4%, P = 0.011, OR = 0.543, 95% CI: 0.325~0.854). CONCLUSIONS: The VDR gene was associated with breast cancer pathogenesis; females carrying the haplotype G-T-T had a lower breast cancer risk, while the haplotype A-G-T conferred a higher risk.
Entities:
Keywords:
Vitamin D receptor; breast cancer; genotype; haplotype
Authors: Kelly Towsend; Victor Trevino; Francesco Falciani; Paul M Stewart; Martin Hewison; Moray J Campbell Journal: Oncology Date: 2007-03-21 Impact factor: 2.935
Authors: Laura N Anderson; Michelle Cotterchio; David E C Cole; Julia A Knight Journal: Cancer Epidemiol Biomarkers Prev Date: 2011-06-21 Impact factor: 4.254
Authors: Srilatha Swami; Nalini Raghavachari; Uwe R Muller; Yijia P Bao; David Feldman Journal: Breast Cancer Res Treat Date: 2003-07 Impact factor: 4.872
Authors: Anurupa Chakraborty; Ashwani K Mishra; Abha Soni; Thodum Regina; R Mohil; D Bhatnagar; A Bhatnagar; Chintamani Chintamani; P C Sharma; Sunita Saxena Journal: Cancer Detect Prev Date: 2009
Authors: Lorraine C Lowe; Michelle Guy; Janine L Mansi; Clare Peckitt; Judith Bliss; Rosalind Given Wilson; Kay W Colston Journal: Eur J Cancer Date: 2005-04-14 Impact factor: 9.162